EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunomodulatory Effect of Phage Depolymerase Dep_kpv74 with Therapeutic Potential Against K2-Hypervirulent Klebsiella pneumoniae

Nikolay V Volozhantsev iD, Maria A Makarova, Alena S Kartseva, Marina V Silkina, Valentina M Krasilnikova, Egor A Denisenko iD, Alexander I Borzilov iD, Victoria V Firstova

Antibiotics · 07.01.2025 · 14 (1) · 44

DOI: 10.3390/antibiotics14010044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 07.01.2025. Verfasst von Nikolay V Volozhantsev und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emergence of multidrug-resistant hypervirulent Klebsiella pneumoniae (hvKp) has made it difficult to treat and control infections caused by this bacterium. Previously, the therapeutic effectiveness of phage-encoded depolymerase Dep_kpv74 in a mouse model of K. pneumoniae-induced thigh soft tissue infection was reported. In this study, the effect of Dep_kpv74 on blood parameters in mice, the proliferation and subpopulation composition of spleen lymphocytes, and the activity and stability of the enzyme at different pH and temperatures were further explored.

Results

The stability tests showed that Dep_kpv74 remained active in the temperature range from 8 °C to 55 °C. The optimal pH value for maintaining the activity of Dep_kpv74 ranged from 5.0 to 9.0. The depolymerase was detected in the blood, spleen, and lungs of mice 10 min after intraperitoneal administration, reaching maximum activity values after 1–3 h and maintaining activity a day after administration. The introduction of Dep_kpv74 at the therapeutic dose (10 μg/mouse) or at a 10-fold higher dose did not lead to reliable changes in bloodstream cell content compared with the reference values of intact mice. The biochemical results of the studies indicated that Dep_kpv74 did not exert any toxic effects on liver and kidney functions. The results of the analysis of lymphocyte proliferative activity demonstrated that Dep_kpv74 depolymerase has a mild immunomodulatory effect.

Conclusions

Thus, the results of this study provide one more confirmation that depolymerase Dep_kpv74 is a potential candidate for the treatment of infections caused by hvKp expressing K2 capsular polysaccharides.

Schlagwörter

Stichwörter der Autor:innen

CD69Klebsiella pneumoniaebacteriophageimmunomodulationlymphocyte proliferationpolysaccharide depolymerase

Autor:innen und Institutionen

  • State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Russia.

ORCID-Profile: Nikolay V Volozhantsev, Egor A Denisenko, Alexander I Borzilov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Volozhantsev, N. V., Makarova, M. A., Kartseva, A. S., Silkina, M. V., Krasilnikova, V. M., Denisenko, E. A., Borzilov, A. I., & Firstova, V. V. (2025). Immunomodulatory Effect of Phage Depolymerase Dep_kpv74 with Therapeutic Potential Against K2-Hypervirulent Klebsiella pneumoniae. Antibiotics, 14(1), 44. https://doi.org/10.3390/antibiotics14010044

Vancouver

Volozhantsev NV, Makarova MA, Kartseva AS, Silkina MV, Krasilnikova VM, Denisenko EA, et al. Immunomodulatory Effect of Phage Depolymerase Dep_kpv74 with Therapeutic Potential Against K2-Hypervirulent Klebsiella pneumoniae. Antibiotics. 2025;14(1):44. doi:10.3390/antibiotics14010044

BibTeX
@article{Volozhantsev2025,
  author = {Volozhantsev, Nikolay V and Makarova, Maria A and Kartseva, Alena S and Silkina, Marina V and Krasilnikova, Valentina M and Denisenko, Egor A and Borzilov, Alexander I and Firstova, Victoria V},
  title = {Immunomodulatory Effect of Phage Depolymerase Dep_kpv74 with Therapeutic Potential Against K2-Hypervirulent Klebsiella pneumoniae},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {44},
  doi = {10.3390/antibiotics14010044}
}
Kostenlos starten →